Search results
Can Pacira (PCRX) Climb 27.68% to Reach the Level Wall Street Analysts Expect?
Zacks via Yahoo Finance· 1 year agoThe consensus price target hints at a 27.7% upside potential for Pacira (PCRX). While empirical...
Pacira BioSciences, Inc. (NASDAQ:PCRX) Stock's Been Sliding But Fundamentals Look Decent: Will The...
Simply Wall St. via Yahoo Finance· 1 year agoIt is hard to get excited after looking at Pacira BioSciences' (NASDAQ:PCRX) recent performance,...
Unveiling Pacira BioSciences (PCRX)'s Value: Is It Really Priced Right? A Comprehensive Guide
GuruFocus.com via Yahoo Finance· 7 months agoWith a day's loss of -2.26%, a 3-month loss of -17.45%, and a Loss Per Share of 0.16, Pacira...
All You Need to Know About Pacira (PCRX) Rating Upgrade to Buy
Zacks via Yahoo Finance· 1 year agoPacira (PCRX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy)....
Pacira BioSciences (NASDAQ:PCRX) stock falls 4.1% in past week as three-year earnings and...
Simply Wall St. via Yahoo Finance· 3 weeks agoThe truth is that if you invest for long enough, you're going to end up with some losing stocks. But...
Loss-making Pacira BioSciences (NASDAQ:PCRX) sheds a further US$83m, taking total shareholder losses...
Simply Wall St. via Yahoo Finance· 7 months agoIn order to justify the effort of selecting individual stocks, it's worth striving to beat the...
A Look At The Fair Value Of Pacira BioSciences, Inc. (NASDAQ:PCRX)
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Pacira BioSciences fair value estimate is...
Are Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Fundamentals Good Enough to Warrant Buying Given The...
Simply Wall St. via Yahoo Finance· 6 months agoIt is hard to get excited after looking at Pacira BioSciences' (NASDAQ:PCRX) recent performance,...
Pacira's (PCRX) Knee Osteoarthritis Drug Gets FDA's RMAT Tag
Zacks via Yahoo Finance· 2 months agoPacira (PCRX) receives the FDA's RMAT designation for its gene-therapy product candidate, PCRX-201,...
Recent 8.4% pullback isn't enough to hurt long-term Pacira BioSciences (NASDAQ:PCRX) shareholders,...
Simply Wall St. via Yahoo Finance· 2 years agoGenerally speaking the aim of active stock picking is to find companies that provide returns that...